Taro Pharmaceuticals Issues Voluntary Nationwide Product Recall of Lamotrigine Tablets Over Cross Contamination
As reported on FDA.gov: on January 10, 2020, Taro Pharmaceuticals U.S.A., Inc. issued a voluntary product recall of one lot of Lamotrigine 100 mg Tablets (Lot # 331771 with expiration date June 2021 in 100 count bottles, NDC 51672-4131-1 to the consumer level). The lot is being recalled because it was found to have been cross-contaminated with a small amount of another drug substance called Enalapril Maleate, that is used to manufacture another pharmaceutical at the same facility. Read the full press release here: https://www.businesswire.com/news/home/20200110005522/en/External Link Disclaimer
(more…)
Read More
0